The influence of proteasome inhibitor bortezamib on ABC transporters' expression and activity in tumor cells

Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

Volumn 4, Issue 2, 2010, Pages 220-225

  Panischeva, L A ^a   Kakpakova, E S ^a   Rybalkina, E Y ^a   Stavrovskaya, A A ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

ABC protein family; multiple drug resistance; proteasome inhibiter

Indexed keywords

ABC TRANSPORTER; BORTEZOMIB; COMPLEMENTARY DNA; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; VINBLASTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 77955504666     PISSN: 19907478     EISSN: 19907494     Source Type: Journal    
DOI: 10.1134/S1990747810020145     Document Type: Article

References (19)

1. H. Glavinas P. Krajcsi J. Cserepes B. Sarkadi 2004 The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity Curr. Drug Delivery 1 27 42 10.2174/1567201043480036 1:CAS:528:DC%2BD2cXhsVSqu7Y%3D
2. A.A. Stavrovskaya 2000 Cellular Mechanisms of Multidrug Resistance of Tumor Cells Biokhimia (Rus.) 65 95 106 1:CAS:528:DC%2BD3cXitVarsLY%3D
3. C.F. Higgins 2007 Multiple Molecular Mechanisms for Multidrug Resistance Transporters Nature 446 749 757 10.1038/nature05630 1:CAS:528: DC%2BD2sXktVeqsbk%3D 17429392 (Pubitemid 46582024)
4. T.P. Stromskaya E.Y. Rybalkina S.S. Kruglov T.N. Zabotina E.B. Mechetner A.G. Turkina A.A. Stavrovskaya 2008 Role of P-Glycoprotein in Evolution of Populations of Chronic Myeloid Leukemia Cells Treated with Imatinib Biokhimia (Rus.) 73 29 37 1:CAS:528:DC%2BD1cXitFKgu7g%3D
5. P.G. Richardson T. Hideshima K.C. Anderson 2003 Bortezomib (PS-341): A Novel, First-in-Class Proteasome Inhibitor for the Treatment of Multiple Myeloma and Other Cancers Cancer Control. 10 361 369 14581890
6. J. Styczynski D. Olszewska-Slonina B. Kolodziej M. Napieraj M. Wysocki 2006 Activity of Bortezomib in Glioblastoma Anticancer Res. 26 4499 4503 1:CAS:528:DC%2BD2sXpslGjug%3D%3D 17201170
7. T. Nakamura K. Tanaka T. Matsunobu T. Okada F. Nakatani R. Sakimura M. Hanada Y. Iwamoto 2007 The Mechanism of Cross-Resistance to Proteasome Inhibitor Bortezomib and Overcoming Resistance in Ewing's Family Tumor Cells Int. J. Oncol. 31 803 811 1:CAS:528:DC%2BD2sXht1SjurbN 17786311
8. H. Minderman Y. Zhou K.L. O'Loughlin M.R. Baer 2007 Bortezomib Activity and in vitro Interactions with Anthracyclines and Cytarabine in Acute Myeloid Leukemia Cells Are Independent of Multidrug Resistance Mechanisms and P53 Status Cancer Chemother. Pharmacol. 60 245 255 10.1007/s00280-006-0367-6 1:CAS:528:DC%2BD2sXltFSkt7w%3D 17096161 (Pubitemid 46742540)
9. H. Rumpold C. Salvador A.M. Wolf H. Tilg G. Gastl D. Wolf 2007 Knockdown of Pgp Resensitizes Leukemic Cells to Proteasome Inhibitors Biochem. Biophys. Res. Commun. 21 549 554 10.1016/j.bbrc.2007.07.049 (Pubitemid 47187282)
10. B.B. Lozzio C.B. Lozzio 1979 Properties and Usefulness of the Original K-562 Human Myelogenous Leukemia Cell Line Leuk. Res. 3 363 370 10.1016/0145-2126(79)90033-X 1:STN:280:DyaL3c3jtFWqtA%3D%3D 95026
11. E.B. Mechetner I.B. Roninson 1992 Efficient Inhibition of P-Glycoprotein-Mediated Multidrug Resistance with a Monoclonal Proc. Natl. Acad. Sci. USA 89 5824 5828 10.1073/pnas.89.13.5824 1:CAS:528:DyaK38XltVektrs%3D 1352877
12. H.P. Koeffler D.W. Golde 1978 Acute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity Science 200 1153 1154 10.1126/science.306682 1:STN:280:DyaE1c7otVGrtw%3D%3D 306682
13. S. Akiyama A. Fojo J.A. Hanover I. Pastan M.M. Gottesman 1985 Isolation and Genetic Characterization of Human KB Cell Lines Resistant to Multiple Drugs Somat. Cell Mol. Genet. 11 117 126 10.1007/BF01534700 1:CAS:528: DyaL2MXhvVejtbo%3D 3856953 (Pubitemid 15149285)
14. E.A. Sherbakova T.P. Stromskaia E.Yu. Rybalkina O.V. Kalita A.A. Stavrovskaia 2008 Role of PTEN Protein in Multidrug Resistance of Prostate Cancer Cells Molek. Biologia (Rus.) 42 430 435
15. S.W. Park N. Lomri L.A. Simeoni J.P. Fruehauf E. Mechetner 2003 Analysis of P-Glycoprotein-Mediated Membrane Transport in Human Peripheral Blood Lymphocytes Using the UIC2 Shift Assay Cytometry A 53 67 78 10.1002/cyto.a.10039 12766968
16. A.V. Vaiman T.P. Stromskaya E.Y. Rybalkina A.V. Sorokin L.P. Ovchinnikov A.A. Stavrovskaya 2007 Development of Drug Resistance in the Population of Colon Cancer Cells under the Effect of Multifunctional Protein YB-1 Bull. Exp. Biol. Med. 143 463 466 10.1007/s10517-007-0157-0 1:CAS:528:DC%2BD2sXhtVGmsbfF 18214301 (Pubitemid 47456582)
17. T.P. Stromskaya E.Y. Rybalkina T.N. Zabotina A.A. Shishkin A.A. Stavrovskaya 2005 Influence of RARα Gene on MDR1 Expression and P-Glycoprotein Function in Human Leukemic Cells Cancer Cell Internat. 5 5 15 10.1186/1475-2867-5-5 (Pubitemid 40617773)
18. A. Yerlikaya N. Erin 2008 Differential Sensitivity of Breast Cancer and Melanoma Cells to Proteasome Inhibitor Velcade Int. J. Mol. Med. 22 817 823 1:CAS:528:DC%2BD1MXks1SqtQ%3D%3D 19020781
19. A.V. Sorokin A.A. Selyutina M.A. Skabkin S.G. Guryanov 2005 Proteasome-Mediated Cleavage of the Y-Box-Binding Protein 1 Is Linked to DNA-Damage Stress Response EMBO J. 24 3602 3612 10.1038/sj.emboj.7600830 1:CAS:528:DC%2BD2MXhtFaht7jN 16193061 (Pubitemid 41509367)